This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wetzel, C. H. R. Articles by Rupprecht, R. Search for Related Content PubMed PubMed Citation Articles by Wetzel, C. H. R. Articles by Rupprecht, R.

Functional Antagonism of Gonadal Steroids at the 5-Hydroxytryptamine Type 3 Receptor

Max Planck Institute of Psychiatry 80804 Munich, Germany

Steroid hormone action involves binding to cognate intracellular receptors that, in turn, bind to respective response elements and thus modulate gene expression. The present study shows that the gonadal steroids, 17ß-estradiol and progesterone, may also act as functional antagonists at the 5-hydroxytryptamine type 3 (5-HT₃) receptor in whole-cell voltage-clamp recordings of HEK 293 cells stably expressing the 5-HT₃ receptor. Functional antagonistic properties at this ligand-gated ion channel could also be shown for 17-estradiol, 17-ethinyl-17ß-estradiol, mestranol, R 5020, testosterone, and allopregnanolone but not for pregnenolone sulfate and cholesterol. An antagonism at the 5-HT₃ receptor could further be observed with the aromatic alcohol 4-dodecylphenol but not with phenol or ethanol. Thus, the modulation of 5-HT₃ receptor function by steroids or alcohols is dependent on their respective molecule structure. The antagonistic action of steroids at the 5-HT₃ receptor is not mediated via the serotonin binding site because the steroids did not alter the binding affinity of [³H]GR65630 to the 5-HT₃ receptor, and kinetic experiments revealed a quite different response pattern to 17ß-estradiol when compared with the competitive antagonist metoclopramide. BSA-conjugated gonadal steroids labeled with fluorescein isothiocyanate bound to membranes of HEK 293 cells expressing the 5-HT₃ receptor in contrast to native HEK 293 cells. However, there was no dose-dependent displacement of the binding of gonadal steroids to membranes of cells expressing the 5-HT₃ receptor in binding experiments or fluorescence studies. Thus, gonadal steroids probably interact allosterically with the 5-HT₃ receptor at the receptor-membrane interface. The functional antagonism of gonadal steroids at the 5-HT₃ receptor may play a role for the development and course of nausea during pregnancy and of psychiatric disorders.

This article has been cited by other articles:

				B. Eisensamer, M. Uhr, S. Meyr, G. Gimpl, T. Deiml, G. Rammes, J. J. Lambert, W. Zieglgansberger, F. Holsboer, and R. Rupprecht Antidepressants and Antipsychotic Drugs Colocalize with 5-HT3 Receptors in Raft-Like Domains J. Neurosci., November 2, 2005; 25(44): 10198 - 10206. [Abstract] [Full Text] [PDF]

				E. E. Shannon, P. Porcu, R. H. Purdy, and K. A. Grant Characterization of the Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone in DBA/2J and C57BL/6J Inbred Mice J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 675 - 685. [Abstract] [Full Text] [PDF]

				I. Ben-Shlomo and A. J. W. Hsueh Three's Company: Two or More Unrelated Receptors Pair with the Same Ligand Mol. Endocrinol., May 1, 2005; 19(5): 1097 - 1109. [Abstract] [Full Text] [PDF]

				R. Halari, V. Kumari, R. Mehrotra, M. Wheeler, M. Hines, and T. Sharma The Relationship of Sex Hormones and Cortisol with Cognitive functioning in Schizophrenia J Psychopharmacol, September 1, 2004; 18(3): 366 - 374. [Abstract] [PDF]

				I. M. Abraham, M. G. Todman, K. S. Korach, and A. E. Herbison Critical in Vivo Roles for Classical Estrogen Receptors in Rapid Estrogen Actions on Intracellular Signaling in Mouse Brain Endocrinology, July 1, 2004; 145(7): 3055 - 3061. [Abstract] [Full Text] [PDF]

				J. Qiu, M. A. Bosch, S. C. Tobias, D. K. Grandy, T. S. Scanlan, O. K. Ronnekleiv, and M. J. Kelly Rapid Signaling of Estrogen in Hypothalamic Neurons Involves a Novel G-Protein-Coupled Estrogen Receptor that Activates Protein Kinase C J. Neurosci., October 22, 2003; 23(29): 9529 - 9540. [Abstract] [Full Text] [PDF]

				N. Azad, S. Pitale, W. E. Barnes, and N. Friedman Testosterone Treatment Enhances Regional Brain Perfusion in Hypogonadal Men J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3064 - 3068. [Abstract] [Full Text] [PDF]

				R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF]

				M. Spehr, H. Hatt, and C. H. Wetzel Arachidonic Acid Plays a Role in Rat Vomeronasal Signal Transduction J. Neurosci., October 1, 2002; 22(19): 8429 - 8437. [Abstract] [Full Text] [PDF]

				Y.-H. Suh and F. Checler Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525. [Abstract] [Full Text] [PDF]

				S. R. Engel, R. H. Purdy, and K. A. Grant Characterization of Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 489 - 495. [Abstract] [Full Text]

				P. Monteleone, M. Luisi, B. Colurcio, E. Casarosa, P. Monteleone, R. Ioime, A. R. Genazzani, and M. Maj Plasma Levels of Neuroactive Steroids Are Increased in Untreated Women With Anorexia Nervosa or Bulimia Nervosa Psychosom Med, January 1, 2001; 63(1): 62 - 68. [Abstract] [Full Text] [PDF]

				E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF]

				M. A. Valverde, P. Rojas, J. Amigo, D. Cosmelli, P. Orio, M. I. Bahamonde, G. E. Mann, C. Vergara, and R. Latorre Acute Activation of Maxi-K Channels (hSlo) by Estradiol Binding to the  Subunit Science, September 17, 1999; 285(5435): 1929 - 1931. [Abstract] [Full Text]

				B. Moosmann and C. Behl The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties PNAS, August 3, 1999; 96(16): 8867 - 8872. [Abstract] [Full Text] [PDF]